InvestorsHub Logo
Followers 232
Posts 8052
Boards Moderated 2
Alias Born 08/28/2014

Re: None

Thursday, 03/19/2020 12:10:54 PM

Thursday, March 19, 2020 12:10:54 PM

Post# of 13735
$ROTH Due Diligence-

BIO-MED company getting current last month,

-Governments of Canada, Germany, Peru, Mexico, India, and UAE have already validated Sucanon through clinical trials and is available in those countries.

-CEO is an ATTORNEY and PROFESSOR

DD of government approvals here-


-Holds international rights to 1 of 3 diabetes treatment drugs, Sucanon

-Company became current and in good standing last month on Colorado SOS. Gearing up for getting current on OTC Markets. (PIC OF GOOD STANDING ON INTRO PAGE)

-ZERO DILUTION (company doesn’t need to raise funds, otherwise they would be diluting!)

-Outstanding shares REDUCED to 351 mill from the 394mill in last filing. (Decrease of float!)

-Company has NEVER had a reverse split, and was trading over .10 after two FORWARD splits.

-Last month Canadian DISTRIBUTION rights were sold for Sucanon for six figures+.

-ZERO convertible debt!

-CEO has confirmed UPDATES ARE
ON THE WAY.

-Float only 200million. You want to be loaded here before the otcmarkets filings start!

All of the DD can be found in the intro !